TY  - CONF

T1  - Baseline N-telopeptide levels correlate with risk of skeletal morbidity in patients with multiple myeloma during zoledronic acid therapy.

JO  - BLOOD

PY  - 2005/11/16

AU  - Lipton A

AU  - Coleman RE

AU  - Major P

AU  - Brown JE

AU  - Lee KA

AU  - Smith M

AU  - Saad F

AU  - Chen YM

AU  - Hei YJ

AU  - Cook R

ED  - 

VL  - 106

IS  - 11

SP  - 964A

EP  - 965A

Y2  - 2024/12/22

ER  -